Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …

Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

Abstract Coronavirus disease 2019 (COVID-19) is a recent pandemic caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) leading to pulmonary and …

Importance New-onset retinal vascular occlusion (RVO) occurring acutely after messenger
RNA (mRNA) COVID-19 vaccination has been described in recent literature. Because RVO …

Introduction. Obesity and metabolic syndrome (MetS) constitute a rapidly increasing health
problem and contribute to the development of multiple comorbidities like acute and chronic …

Abstract Coronavirus disease 19 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome 2 (SARS-CoV-2). Throughout the pandemic, evidence on the …

In our previous randomized controlled trial, we documented significant improvements in
cognitive, psychiatric, fatigue, sleep, and pain symptoms among long Coronavirus disease …

In response to different viral infections, including SARS-CoV-2 infection, pro-inflammatory,
anti-inflammatory cytokines, and bioactive lipids are released from infected and immune …

Abstract Coronavirus disease 2019 (Covid‐19) is caused by a novel severe acute
respiratory syndrome coronavirus virus type 2 (SARS‐CoV‐2) leading to the global …

Dantrolene (DTN) is a ryanodine receptor (RyR) antagonist that inhibits Ca2+ release from
stores in the sarcoplasmic reticulum. DTN is mainly used in the management of malignant …